1 completed, 1 enrolling by invitation. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 2 | Completed 1, Enrolling by invitation 1 |
Follow Myelokathexis: new trials by email Literature Review of Myelokathexis trials Research Report on Myelokathexis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Busulfan, Palifermin, Plerixafor - WHIM, Warts | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2026-10-21 | 2026-10-27 |
| A Phase I Study of Mozobil in the Treatment of Patients With WHIMS Mozobil (TM) - Leukopenia, Neutropenia | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 14 | 2010-01-06 | 2026-09-28 |
Agammaglobulinemia (2) · Immunologic Deficiency Syndromes (2) · Warts (2) · Infections (1) · Leukopenia (1) · Neutropenia (1)
Blood Protein Disorders (2) · DNA Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Papillomavirus Infections (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Viral (2) · Skin and Connective Tissue Diseases (2) · Tumor Virus Infections (2) · Virus Diseases (2) · Agranulocytosis (1)
plerixafor (2) · Busulfan (1) · Fibroblast Growth Factor 7 (1) · Filgrastim (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2)
David H McDermott, M.D. (1) · Suk S De Ravin, M.D. (1)